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ORIGINAL ARTICLE
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BACKGROUND Infection with Zika virus (ZIKV) manifests in a broad spectrum of disease ranging from mild illness to severe 
neurological complications and little is known about Zika immunopathogenesis.
OBJECTIVES To define the immunologic biomarkers that correlate with acute ZIKV infection.
METHODS We characterized the levels of circulating cytokines, chemokines, and growth factors in 54 infected patients of both 
genders at five different time points after symptom onset using microbeads multiplex immunoassay; comparison to 100 age-
matched controls was performed for statistical analysis and data mining.
FINDINGS ZIKV-infected patients present a striking systemic inflammatory response with high levels of pro-inflammatory 
mediators. Despite the strong inflammatory pattern, IL-1Ra and IL-4 are also induced during the acute infection. Interestingly, 
the inflammatory cytokines IL-1b, IL-13, IL-17, TNF-a, and IFN-g; chemokines CXCL8, CCL2, CCL5; and the growth factor 
G-CSF, displayed a bimodal distribution accompanying viremia. While this is the first manuscript to document bimodal 
distributions of viremia in ZIKV infection, this has been documented in other viral infections, with a primary viremia peak 
during mild systemic disease and a secondary peak associated with distribution of the virus to organs and tissues.
MAIN CONCLUSIONS Biomarker network analysis demonstrated distinct dynamics in concurrence with the bimodal viremia 
profiles at different time points during ZIKV infection. Such a robust cytokine and chemokine response has been associated with 
blood-brain barrier permeability and neuroinvasiveness in other flaviviral infections. High-dimensional data analysis further 
identified CXCL10, a chemokine involved in foetal neuron apoptosis and Guillain-Barré syndrome, as the most promising 
biomarker of acute ZIKV infection for potential clinical application.
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The Zika virus (ZIKV) is an arthropod-borne Fla-
vivirus, transmitted mainly by female Aedes mosquitos 
and it that usually causes a mild illness characterized 
by conjunctivitis, pruritus, muscle and joint pain, rash, 
and slight fever. Outbreaks of ZIKV infection were 
first recorded in Micronesia and later in French Polyne-
sia, where atypical manifestations were initially docu-
mented, including Guillain-Barré syndrome (Oehler et 
al. 2014). In Brazil, ZIKV infection during pregnancy 
has been linked to an unusual increase in the number 
of microcephaly cases (de Oliveira et al. 2016). Follow-
ing the Brazilian report of congenital malformations, the 
number of microcephaly cases in French Polynesia was 
reanalysed, and a connection with ZIKV was further es-
CXCL10 overexpression in acute ZIKV infection • Felipe Gomes Naveca et al.2|13
tablished. The broad spectrum of foetal clinical mani-
festations resulting from ZIKV infection led to a new 
classification termed congenital Zika syndrome.
The host immune response plays an important role in 
the clinical course of patients with viral infection. Par-
ticularly, cellular immunity and key components of the 
innate immune response, such as interferons and other 
cytokines/chemokines, play an essential role in limiting 
viral spread. To date, only two studies describing immune 
mediators in Zika-infected patients have been reported 
(Tappe et al. 2016, Kam et al. 2017). In Tappe et al. (2016), 
a reliable immunological biomarker profile during acute 
infection could not be established due to the small sample 
size. Kam et al. (2017) describes immune markers from 
a cohort from Campinas, Brazil, showing an inflamma-
tory immune response and several immune mediators 
specifically higher in ZIKV-infected patients, with a sta-
tistically significant difference was observed in the levels 
of CXCL10, IL-10, and HGF observed between patients 
with and without neurological complications. Kam et al. 
(2017) also found higher levels of CXCL10, IL-22, MCP-1, 
and TNF-α in ZIKV-infected pregnant women carrying 
babies with foetal growth associated malformations.
In this study, we evaluated the immune response dur-
ing acute ZIKV infection by analysing the serum levels of 
cytokines, chemokines, and growth factors from an adult 
cohort of 54 ZIKV-infected cases and 100 controls from 
Manaus, Brazil over five time points during symptomatic 
ZIKV infection. We present the time course of cytokine 
response in relation to viremia and identify a chemokine 
that may serve as a biomarker of acute ZIKV infection, thus 
providing new insights into ZIKV neuropathogenesis.
MATERIALS AND METHODS
Study population and design - We used non-probabi-
listic convenience sampling and a cross-sectional experi-
mental design, together with robust statistical analysis and 
data mining, for the evaluation of the immunological bio-
marker profile during acute ZIKV infection. In the first 
half of 2016, a total of 54 suspected ZIKV-infected cases 
(29 non-pregnant females and 25 males, all adults) were 
recruited at Hospital Adventista de Manaus, Amazonas 
state, Brazil. All patients presented a maculopapular rash, 
with or without fever, and at least one of the following 
symptoms: pruritus, arthralgia, joint swelling, or conjunc-
tival hyperemia within five days after symptom onset. 
Age-matched non-infected (NI) controls, 46 females and 
54 males, were enrolled for comparison and basic char-
acteristics, including data from physical examination and 
virological findings, were obtained. Comprehensive labo-
ratory records, including routine laboratory tests, were 
available for 21 patients (15 male and six female).
Ethics statement - The study protocol was approved 
by the Ethics Committee of the Universidade do Estado 
do Amazonas (CAAE: 56745116.6.0000.5016), and all 
subjects provided written informed consent.
Differential molecular diagnosis of Zika and viral 
load estimative - Serum samples were sent to Fiocruz 
Amazônia and tested for ZIKV (envelope coding region) 
(Lanciotti et al. 2008), chikungunya virus (CHIKV) (Lan-
ciotti et al. 2007), dengue virus (DENV) (Gurukumar et 
al. 2009), Mayaro virus (MAYV) and Oropouche virus 
(OROV) (Naveca et al. 2017) by real-time quantitative 
polymerase chain reaction (RT-qPCR). Samples positive 
for CHIKV, DENV, MAYV, or OROV were excluded from 
further analysis. Sample inclusion criteria also required 
the internal control (spiked MS2 bacteriophage) to display 
a Ct value between 30-32. The viremia was estimated by 
RT-qPCR using absolute quantification by the standard 
curve method and reported as viral RNA copies /mL.
Dengue virus serology - Serum samples were tested 
for previous exposure to DENV using Serion ELISA 
classic Dengue Virus IgG (Institut Virion/Serion GmbH, 
Germany).
Microbeads assay for serum biomarkers - A high-per-
formance microbeads 27-plex assay (Bio-Rad, Hercules, 
CA, USA) was employed for detection and quantification 
of multiple targets, including: CXCL8 (IL-8), CXCL10 
(IP-10), CCL11 (Eotaxin), CCL3 (MIP-1α), CCL4 (MIP-
1β), CCL2 (MCP-1), CCL5 (RANTES), IL-1β, IL-6, 
TNF-α, IL-12, IFN-g, IL-17, IL-1Ra (IL-1 receptor an-
tagonist), IL-2, IL-4, IL-5, IL-7, IL-9, IL-10, IL-13, IL-15, 
FGF-basic, PDGF, VEGF, G-CSF, and GM-CSF. Samples 
were tested on a Bio-Plex 200 instrument (Bio-Rad) ac-
cording to the manufacturer’s instructions. The serum 
levels of IL-2, IL-7, and IL-15 were below the detection 
limits in several samples and were excluded from further 
analysis. The results were expressed as pg/mL.
Statistical analysis and data mining - Statistical 
analyses were initially performed using GraphPad Prism 
(GraphPad Software 6.0, San Diego, CA, USA). Compar-
ative analysis of the clinical records was carried out using 
Fisher’s exact test. The analysis of biomarker levels in NI 
controls vs. ZIKV-infected cases and between genders 
was performed using Mann-Whitney U tests. Multivariate 
correlations for biomarker levels and routine laboratory 
tests were analysed with the nonparametric Spearman’s 
test (alpha .05) running on the JMP Software, v13.1.0 
(SAS Institute, Cary, NC, USA). Correlations (Spearman 
r) were represented by a colour map matrix.
The dynamics of viremia, chemokines, cytokines, 
and growth factors were evaluated using the median 
value of each analyte. Comparative analysis of the bio-
markers was carried out by Kruskal-Wallis test followed 
by Dunn’s test. For all tests, differences were considered 
significant when p <.05 using two-tailed tests.
Data management strategies were applied to identify 
general and time-specific profiles. Biomarker signature 
analysis was carried out as previously described (Luiza-
Silva et al. 2011). Radar charts were used to compile the 
biomarker signatures of NI controls and ZIKV-infected 
cases, applying the 75th percentile as the threshold. Venn 
diagrams were created to identify shared and unique at-
tributes, along with the timeline of the symptoms on-
set (http://bioinformatics.psb.ugent.be/webtools/Venn/). 
Cytoscape software v3.2.0 (http://www.cytoscape.org/) 
was employed for visualizing and integrating multiple 
attributes into circular nodal networks. Connecting edg-
es were drawn to underscore each association as posi-
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tive (solid line) or negative (dashed line). The biomarker 
cluster pattern was defined by heatmaps assembled us-
ing R software (heatmap.2 function; v3.0.1). Decision 
tree algorithms were generated with WEKA software 
v3.6.11 (University of Waikato, New Zealand) to iden-
tify root and branch attributes and segregate patients 
from controls. ROC curves were built to define the cut-
off and identify biomarkers with better performance in 
discriminating ZIKV-infected patients from NI controls. 
Performance indices (co-positivity, co-negativity, posi-
tive and negative likelihood ratios) were calculated using 
MedCalc software v7.3 (Ostend, Belgium).
RESULTS
Demographics, clinical records and virological data 
- The 54 Brazilian Zika cases, 29 non-pregnant females 
(median age 38 years, interquartile range (IQR) 27.5 - 
46.5) and 25 males (median age 37 years, IQR 30 - 50), 
were enrolled between the first and fifth day after symp-
tom onset. A group of 100 non-infected control subjects 
who were residents of Manaus, Amazonas, Brazil were 
also included (46 females (median age 28 years, IQR 
23 - 36) and 54 males (median age 29.5 years, IQR 23 - 
36). The median viremia level, expressed as copies/mL, 
was 2,031 (minimum = 133, maximum = 2.4 x 106, IQR: 
881 - 5,268). The frequency of specific ZIKV symptoms 
was similar between men and women, with the excep-
tion that men had an increased frequency of fever com-
pared to women (100% versus 67%, p = 0.005) (Table 
I). DENV IgG testing showed that 94.4% (51/54) of the 
patients were positive, two had an undetermined result, 
and one male subject was negative.
Correlation of immunological biomarkers with rou-
tine laboratory tests during acute ZIKV infection - The 
data on 45 continuous variables including immunologi-
cal biomarkers, routine laboratory tests, age, viremia, 
and symptoms onset were analysed (Fig. 1A). Overall, 
moderate correlations were observed for several vari-
ables, and the strongest correlations were observed be-
tween TNF-a and CCL5 (Spearman r = 0.8245), and 
lymphocytes (%) and neutrophils (%) (Spearman r = 
0.8084). All results were represented in a colour map 
matrix, where statistically supported associations (p 
<.05) between routine laboratorial tests and immuno-
logical biomarkers were highlighted (Fig. 1B).
ZIKV-infected patients display high levels of circulat-
ing biomarkers - Elevated levels of pro-inflammatory cy-
tokines (IL-1β, IL-6, TNF-α, IFN-g and IL-17, except IL-
12, which was higher in controls), chemokines (CXCL8, 
CCL11, CCL3, CCL4, CCL2, CCL5, and CXCL10) and 
growth factors (FGF-basic, PDGF, VEGF, G-CSF, and 
GM-CSF) were found in ZIKV-infected cases (Fig. 2, 
pink panels), whereas higher levels of IL-5 and IL-13 were 
seen in controls (Fig. 2, blue panels). Interestingly, the lev-
els of IL-4 and IL-1Ra were also higher among patients 
as compared to controls. No differences were observed 
for IL-9 and IL-10 (Fig. 2, grey panels). A similar pat-
TABLE I
Demographical aspects, clinical records and virological status of Zika virus (ZIKV)-infected patients
Parameters All Females Males p
Non-infected controls
n 100 46 54 NA
Age (years) 29.0 (23-36) 28.0 (23-36) 29.5 (23-36) 0.58
ZIKV-infected patients
n 54 29 25 n.a.
Age (years) 37.5 (29-48) 38.0 (27.5-46.5) 37.0 (30-50) 0.79
Days of symptoms onset 2.5 (2-4) 2.0 (1-4) 3.0 (2-4) 0.32
Rash 95.0% 94.4% 95.5% 1.00
Fever 85.0% 66.7% 100.0% 0.005
Myalgia 82.5% 83.3% 81.8% 1.00
Conjunctival hyperemia 75.0% 66.7% 81.8% 0.30
Pruritus 70.0% 66.7% 72.7% 0.73
Headache 65.0% 66.7% 63.6% 1.00
Arthralgia 60.0% 72.2% 50.0% 0.20
Joint swelling 25.0% 33.3% 18.2% 0.30
Vomiting or nausea 25.0% 33.3% 18.2% 0.30
Diarrhea 17.5% 27.8% 9.1% 0.21
Lymphadenopathy 12.5% 11.1% 13.6% 1.00
Viremia (ZIKV RNA copies/mL) 2,031 (881-5,268) 2,130 (1,078-5,268) 1,786 (802-8,720) 0.77
Data are reported as median and interquartile range (IQR) for age, days of symptoms onset and viremia. Statistical differences 
were assessed by Mann-Whitney test. Comparative analysis of clinical records observed in females and males was carried out by 
Fisher’s exact test. Significant differences were considered at p < 0.05 for comparisons between females vs. males and are under-
scored by bold/underlined format. Viremia is expressed as copies /mL as described in material and methods. NA: not applicable.
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tern was observed when results were stratified by gender, 
although infected males presented significant lower levels 
of CCL3, CCL4, CCL5, IL-17, FGF-basic, and GM-CSF 
than females. No significant differences were observed 
between female and male controls (Table II).
Bimodal viremia is accompanied by increased levels 
of a defined group of biomarkers - Viremia and biomarker 
levels were assessed at different time points (day 1 upon 
symptoms onset was denoted as D1, etc.), with D1 (n = 11), 
D2 (n = 13), D3 (n = 10), D4 (n = 09), and D5 (n = 05). A bi-
modal distribution was observed, with two viremia peaks 
at D2 and D4, with the lowest viremia levels at D5 (Fig. 
3, grey panel). Dynamics of CCL5, TNF-a, IFN-g, IL-17, 
and G-CSF were closely related to viremia (Fig. 3A). A 
similar bimodal distribution was observed for IL-1b and 
IL-13 (Fig. 3B). The highest levels of CXCL8 and CCL2 
were observed at D1 and D2 (Fig. 3C). An inverse cor-
relation was observed for IL-12, IL-10, and VEGF (Fig. 
3D), where the highest levels were observed at the lowest 
levels of viremia. The levels of CCL3, CXCL10, IL-6, and 
FGF-basic displayed a distinct pattern, with the lowest 
levels observed at D3, coinciding with the first drop in 
viremia (Fig. 3E). A valley at D4 followed by an increase 
at D5 was observed for CCL11, CCL4, IL-1Ra, and IL-4 
(Fig. 3F), and unique patterns were observed for IL-5, IL-
9, PDGF, and GM-CSF (Fig. 3G).
Biomarkers were also evaluated in controls, and the 
IQR are represented by dashed lines (Fig. 4). Most bio-
marker levels differed between patients and controls at 
all time points, except for IL-10 at D1 and D2, and IL-1b 
at D3. No differences were observed for IL-9.
ZIKV infection elicited a set of general and timeline-
specific biomarkers - The biomarker levels were used to 
build a signature (Fig. 5A-B) as described in the Meth-
ods section. A significant difference in the overall pro-
file was observed in ZIKV-infected cases as compared 
to controls. Furthermore, the radar chart revealed that 
19/24 (79%) biomarkers were highly induced by ZIKV 
infection. Almost all biomarkers analysed were found at 
levels above the global median in more than 75% of the 
infected patients (Fig. 5, B panel).
Venn diagram analysis showed that four chemokines 
(CCL4, CCL2, CCL5, CXCL10), two cytokines (IL-6, IL-
4), and two growth factors (PDGF, G-CSF) were signifi-
cantly induced at all time points (Fig. 5C). Of note, TNF- 
a appears as the only biomarker at the intersection of the 
viremia peaks (D2 and D4). In contrast, IL-10 is the only 
unregulated biomarker at viremia valleys (D3 and D5), 
while increased levels of IL-12 appear at D5 (Fig. 5D).
Fig. 1: immunological biomarker correlations with the results of routine laboratory tests, age, viremia, and symptoms. The nonparametric 
Spearman’s test was applied to evaluate multiple correlations between immunological biomarkers and the results of routine laboratory tests. 
A colour map matrix was plotted showing the strength and direction of these correlations (-1 blue, to +1 red), panel A. Statistically significant 
correlations (p < .05) between immunological biomarkers and routine tests are highlighted in the inserted table, panel B.
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Distinct biomarker networks are observed at differ-
ent time points - Cytoscape software was used to con-
duct a correlative analysis of immunological biomark-
ers. The exploratory analysis demonstrated that earlier 
infection was associated with more complex biomarker 
networks. Most correlations at D1 and all correlations at 
D2 were positive (solid lines). The level of complexity 
decreased from D1 to D5 (Fig. 6).
High-dimensional data analysis identified CXCL10 
as the most promising biomarker for a putative clini-
cal application - A heatmap matrix was constructed to 
evaluate the profile of biomarkers associated with ZIKV 
infection. CXCL10 clustered with one clade separately 
from the other attributes (Fig. 7A). In addition, a deci-
sion tree was built to identify the biomarker most able to 
segregate patients. This approach confirmed the heatmap 
observations indicating CXCL10 as the most specific 
biomarker, followed by IL-4 and VEGF. The analysis 
showed a very high global accuracy (99.4%) with a leave-
one-out cross-validation of 96.8% (Fig. 7B). The signifi-
cance of these attributes (CXCL10, IL-4, and VEGF) was 
assessed by 3D-plots, and the performance of the root at-
tribute (CXCL10) was evaluated by scatterplot distribu-
tion and ROC curve analysis (Fig. 7C-D). CXCL10 alone 
showed a very high global accuracy ranging from 0.952-
0.998. Together, the results demonstrated that CXCL10 
measurement identified 94% of the patients, with no false 
positive identification and outstanding indices (co-posi-
tivity, co-negativity, and likelihood ratio).
DISCUSSION
The pathogenesis of ZIKV infection is still largely 
unknown, and the main determinants of disease man-
ifestations are not yet well established. Understanding 
serum immunomodulators during acute infection may 
be a first step in elucidating the mechanisms underlying 
ZIKV-induced immunopathology.
Fig. 2: panoramic overview of serum chemokines, cytokines, and growth factors during early stages of Zika virus (ZIKV) infection in adults. 
Serum biomarkers (CXCL8, CCL11, CCL3, CCL4, CCL2, CCL5, CXCL10, IL-1β, IL-6, TNF-α, IL-12, IFN-g, IL-17, IL-1Ra, IL-4, IL-5, IL-9, 
IL-10, IL-13, FGF-basic, PDGF, VEGF, G-CSF, and GM-CSF) were measured in ZIKV-infected patients (D1 to D5, ZIKV = , n = 54) and 
non-infected subjects [non-infected (NI) = , n = 100] by high performance Luminex 27-plex assay as described in Methods. Data are ex-
pressed as pg/mL and are displayed in box and whisker (10-90 percentile) plots. Comparative analysis between NI vs. ZIKV was performed by 
Mann-Whitney test and significant differences at p < .05 are underscored by connecting lines. Coloured backgrounds highlight increased (pink), 
decreased (blue), and unaltered (grey) levels of serum biomarkers in ZIKV as compared to NI.
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We show that the immune response during the acute 
phase of ZIKV infection is polyfunctional and broadly in-
flammatory, as evidenced by significantly elevated levels 
of IL-4, IL-17, IFN-g, IL-1b, IL-1Ra, TNF-a, and IL-6 in 
patients as compared to controls. This is consistent with 
findings from Kam et al. (2017) that a robust pro-inflam-
matory cytokine response occurs during acute ZIKV in-
fection, with elevations of IL-18, TNF-α, IFN-g, IL-8, IL-
6, GRO-α, and IL-7. A polyfunctional immune activation 
associated with increased CCL2, CXCL10, IL-6, IL-8, 
VEGF, and G-CSF levels but decreased levels of IL-13 
was also described in the amniotic fluid of ZIKV-pos-
itive pregnant women whose infants had microcephaly 
(Ornelas et al. 2017). Additionally, other studies found 
higher serum levels of IL-5 and IL-13 amongst healthy 
controls as compared to infected individuals (Galliez et 
al. 2016, Kam et al. 2017). Both IL-5 and IL-13 are ef-
fector molecules essential to type 2-inflammation, espe-
cially in atopic asthma and viral respiratory tract infec-
tions (Edwards et al. 2017). However, the role of these 
cytokines in the ZIKV-host response is still unclear.
When we stratified the results by gender, ZIKV-infect-
ed males presented lower levels of CCL3, CCL4, CCL5, IL-
17, FGF-basic, and GM-CSF. The reason for this difference 
is unknown in the context of ZIKV infection; however, 
this finding is consistent with the literature demonstrating 
that females tend to mount a higher innate and adaptive 
immune system response to viruses as compared to men 
(Klein 2012). In addition, this discrepancy could be due 
to females being sampled on average one day earlier than 
men, with a median time from onset to diagnostic sampling 
of two days for females and three days for males.
It is possible that previous exposure to flavivirus anti-
gens may affect the immune response to ZIKV infection. 
In the present study, almost all patients (51/54) tested pos-
itive for DENV IgG antibodies. Manaus has had several 
dengue epidemics, including co-circulation of different 
serotypes (Figueiredo et al. 2008). Moreover, the Ama-
Fig. 3: rhythms of viremia, chemokines, cytokines, and growth factors during early stages of Zika virus (ZIKV) infection in adults. Cross-sectional 
follow-up of viremia and serum biomarkers was carried out in ZIKV-infected patients categorized according to the time (days) of symptom onset 
(D1, n = 11; D2, n = 13; D3, n = 10; D4 n = 9 and D5 n = 5). Viremia displayed a bimodal profile with similar waves at D2 and D4 (grey panel). 
Distinct patterns were identified for clusters of biomarkers, as they displayed kinetic curves shaping a bimodal wave at D2 and a higher wave [   ] 
at D4 (panel A: CCL5, TNF-α, IFN-g, IL-17, and G-CSF); a bimodal profile with similar waves at D2 and D4 (panel B: IL-1β and IL-13); a wave at 
D2 and a valley at D3 (panel C: CXCL8 and CCL2); a midpoint wave at D3 (panel D: IL-12, IL-10, and VEGF); a unimodal valley at D3 (panel E: 
CCL3, CXCL10, IL-6, and FGF-basic); a valley at D4 (panel F: CCL11, CCL4, IL-1Ra, and IL-4) or a unique pattern (panel G: IL-5, IL-9, PDGF, 
and GM-CSF). Data are displayed as global maximum equalized median values of the serum concentrations (pg/mL) for each biomarker.
→
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zonas state is endemic for the yellow fever virus (YFV) 
and has very high YFV-vaccination coverage. Thus, most 
individuals enrolled in this study experienced previous 
flavivirus exposure potentially modulating the cytokine 
and chemokine responses. These differences in prior fla-
vivirus exposure may account for some differences in the 
cytokine and chemokine profiles shown in the study by 
Kam et al. (2017), which examined a Brazilian cohort of 
patients from Campinas, Brazil, where yellow fever vac-
cination was not required by the government at the time 
of their study as it is in Manaus, Brazil.
Consistent with our results, an immune response in-
duced during the acute phase has previously been de-
scribed in infections caused by ZIKV and other flavivi-
ruses, including YFV and West Nile virus (ter Meulen et 
al. 2004, Klein et al. 2005, Tappe et al. 2016). In the case 
of ZIKV infection, the mechanism of the inflammatory 
immune response has not been clearly delineated. The 
immune response may be triggered by viral upregula-
tion of the expression of pattern recognition receptors 
(PRRs) engaged in downstream pathways and the in-
flammatory antiviral response, such as IRF7, IFN-α, 
IFN-β, and CCL5 (Hamel et al. 2015). Interestingly, we 
showed a strong positive correlation between IFN-α and 
CCL5, suggesting that the synergistic effect of these 
cytokines might be crucial for the outcome of acute in-
flammation caused by ZIKV.
Our findings also revealed higher levels of growth 
factors and chemokines among patients as compared 
to controls. Similarly, prior research showed increased 
levels of CXCL10, CCL5, CCL3, and VEGF in patients 
acutely infected with ZIKV, while elevated levels of GM-
CSF, CCL4, and FGF-basic biomarkers were observed 
only in the recovery phase (Tappe et al. 2016). Our study 
Fig. 4: kinetics of viremia, serum chemokines, cytokines, and growth factors during early stages of Zika virus (ZIKV) infection in adults. Cross-
sectional analysis of viremia and serum biomarkers was performed in ZIKV-infected patients categorized according to the time (days) of symp-
tom onset (D1, n = 11; D2, n = 13; D3, n = 10; D4, n = 09 and D5, n = 05). ZIKV RNA copies/mL are displayed as the median and interquartile 
range (IQR). Biomarker data are expressed in pg/mL and are displayed in box and whisker (10-90 percentile) plots. Multiple comparisons amongst 
distinct time points of symptom onset were performed by Kruskal-Wallis test followed by Dunn’s post-test. Significant differences at p < .05 were 
identified at D1, D2, D3, and D4 as compared to day 1, day 2, day 3, and day 4, respectively. Analysis was also carried out by Mann-Whitney test 
to compare each time point from ZIKV-infected patients with those from a single group of non-infected controls (NI). Significant differences at p 
< .05 are marked by asterisks (*). Reference ranges for each biomarker were established as interquartile ranges (25th-75th percentiles) observed in 
NI (dashed lines). Distinct patterns were identified for clusters of biomarkers, as they displayed kinetic curves shaping a bimodal wave at D2 and 
a higher wave [   ] at D4 (CCL-5, TNF-α, IFN-g, IL-17, and G-CSF), a bimodal profile with similar waves at D2 and D4 (IL-1β and IL-13), a wave 
at D2 and a valley at D3 (CXCL8 and CCL2), a midpoint wave at D3 (IL-12, IL-10, and VEGF), a unimodal valley at D3 (CCL3, CXCL10, IL-6, 
and FGF-basic), a valley at D4 (CCL11, CCL4, IL-1Ra, and IL-4) or a unique pattern (IL-5, IL-9, PDGF, and GM-CSF).
→
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Fig. 5: biomarker levels upon symptom onset and along a time course during early stage Zika virus (ZIKV) infection in adults. Biomarker 
signatures of non-infected (NI) ( ) and ZIKV ( ) were constructed as described in Methods. Data are presented in radar charts as the pro-
portion of subjects with serum biomarker levels above the global population median values in (A) NI subjects, and (B) ZIKV-infected patients. 
Biomarkers with levels above the global median in more than 75% of subjects were highlighted by asterisks (*). (C) A Venn diagram showing 
the intersections of common attributes and well as selected biomarkers along the timeline of symptom onset: day 1 (blue), day 2 (red), day 3 
(brown), day 4 (yellow), and day 5 (green). (D) Venn diagram report summarizing selected attributes with patterns labelled as (a) universal, (b) 
peak of viremia, (c) valley of viremia, or (d) late biomarkers (inserted table).
demonstrated that all chemokines and growth factors 
analysed were significantly increased in the acute phase 
when compared with non-infected controls. In fact, the 
role of growth factors in the pathogenesis of arboviral 
infections remains a matter of debate. We demonstrate 
that a remarkable increase of FGF-basic, PDGF, VEGF, 
G-CSF, and GM-CSF identifies the acute phase of ZIKV 
infection, which suggests the importance of chemokines 
and growth factors in the initiation and regulation of the 
acute phase immune response.
Increased serum concentrations of both CXCL (CXCL8 
and CXCL10) and CCL chemokines (CCL2, CCL3, CCL4, 
CCL5, and CCL11) were found in acute ZIKV infection. 
The role of CCL5 in arbovirus-induced immunopathology 
remains a controversial issue, but levels of this chemokine, 
along with CCL2 and CCL3, were previously linked to the 
severity of dengue virus infections, including neurological 
disease and impairment of neuronal survival (Sathupan et 
al. 2007, Zlotnik and Yoshie 2012).
Furthermore, we found strong correlations between 
TNF-a and CCL5 concentrations and the percentages of 
circulating neutrophils and lymphocytes in acute ZIKV 
infection. This finding is likely due to the role of TNF-a 
and CCL5 in leukocyte chemoattraction and demon-
strates the important role of this cytokine and chemok-
ine in the stimulation of the innate and adaptive immune 
system in response to ZIKV infection.
This manuscript is the first to describe the bimodal 
nature of viremia in acute Zika infection and the corre-
sponding peaks in inflammatory cytokine production. A 
biological model explaining bimodal viremia was first de-
scribed in a classical study of using mousepox virus (Fen-
ner 1948). Similarly, flaviviruses are initially replicated in 
Langerhans cells at the site of inoculation and in draining 
regional lymph nodes. Despite a robust antiviral innate im-
mune response that eliminates viral infected cells, some 
virus particles are disseminated by the blood (primary 
viremia). Therefore, several organs and tissues may be-
CXCL10 overexpression in acute ZIKV infection • Felipe Gomes Naveca et al.10|13
Fig. 6: biomarker networks along a timeline during early stages of Zika virus (ZIKV) infection in adults. Integrative systems biology analysis 
of attributes was conducted using the Cytoscape software platform to build a circular nodal network layout for each time point following ZIKV 
infection, from day 1 (D1) up to day 5 (D5), based on Spearman’s correlation matrices. Significance was considered at p < .05. The timeline of 
networks is displayed as circular layouts to characterize the interaction along the early time points. Coloured nodes are employed to identify 
chemokines (CH - orange), pro-inflammatory cytokines (PI - red), regulatory cytokines (RG - green), and growth factors (GF - yellow). Con-
necting edges underscore the association between attributes, classified as positive (solid line) or negative (dashed line).
come infected, producing a second wave of viral replica-
tion that reaches the blood and causes secondary viremia. 
The equine infection by African horse sickness virus, an-
other arbovirus of the Orbivirus genus, Reoviridae family, 
also shows two viremia peaks. The first peak is observed 
after viral multiplication in lymph nodes, whereas the sec-
ond peak is observed after viral replication in spleen, lungs 
and endothelial cells (Mellor and Hamblin 2004).
Interestingly, bimodal viremia has been found in pa-
tients after low dose live attenuated 17DD yellow fever 
vaccine administration (Campi-Azevedo et al. 2014). As 
compared to the standard dosage vaccine, the low dose 
live attenuated vaccine is hypothesized to elicit a less 
robust immune response that does not clear the initial 
viremia, leading to a second peak of viremia a few days 
later. Although bimodal viremia, including in flavivirus 
infections, was observed in the aforementioned studies, 
our results should be interpreted with caution, as we did 
not evaluate patients longitudinally. Thus, future studies 
on this topic are recommended.
In this manuscript, we report high levels of pro-in-
flammatory mediators during the acute phase of ZIKV 
infection. Paradoxically, although the inflammatory re-
sponse leads to viral clearance, the high levels of circu-
lating pro-inflammatory biomarkers may facilitate the 
transmission of viruses from the circulation to the cen-
tral nervous system by increasing the permeability of the 
blood-brain barrier. This phenomenon has been reported 
for the West Nile virus (Wang et al. 2004), as well as an-
other neurovirulent flavivirus, and may partially explain 
ZIKV neuroinvasiveness.
Remarkably, CXCL10 expression was increased 
more than 200-fold in ZIKV-infected subjects as com-
pared to controls. This CXCL10 overexpression has 
been linked to the IFN-g signalling pathway induced 
by ZIKV NS5 protein. According to Chaudhary et al. 
(2017), NS5 promotes IFN-g gene activation through 
the degradation of STAT2 and subsequent induction of 
STAT1-STAT1 homodimerization. Augmented serum 
levels of CXCL10 have been found during severe clinical 
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Fig. 7: high-dimensional data analysis during early stages of Zika virus (ZIKV) infection in adults. Machine-learning high-dimensional data ap-
proaches were applied to further explore and identify feasible criteria applicable for the clinical follow-up of ZIKV infection. (A) Heatmap panels 
were built to verify the ability of attributes to segregate ZIKV (orange) and non-infected (NI) (blue) groups as they present low (green) or high (red) 
levels of serum biomarkers. (B) Decision tree algorithms were generated to define root and branch attributes to segregate patients (ZIKV = orange) 
from NI controls (NI = blue). Global accuracy and leave-one-out cross-validation (LOOCV) values are provided in the figure. (C) The root/branch 
attributes selected by the decision tree algorithm were compiled into a 3D-plot to verify their cluster strengths. (D) The performance of the selected 
root attribute to discriminate ZIKV (orange) from NI (blue) was evaluated by scatterplot distribution and validated by receiver operating character-
istic indices (AUC: area under the curve; Cp: co-positivity; Cn: co-negativity; LR+/LR-: positive/negative likelihood ratio).
manifestations of dengue and yellow fever (Melchjorsen 
et al. 2003). Surprisingly, CXCL10 has also been shown 
to play an important role in CD-8+ T-cell recruitment 
as part of an anti-flaviviral response to West Nile virus 
in the central nervous system (Klein et al. 2005). Fur-
thermore, CXCL10 has been previously identified as a 
biomarker of severity in several diseases including those 
caused by bacteria such as Mycobacterium tuberculosis 
and Legionella pneumophila, as well as protozoans like 
Trypanosoma brucei, Leishmania major, Plasmodium 
vivax or Plasmodium falciparum (Liu et al. 2011). Other 
studies showed that the overexpression of CXCL10 leads 
to apoptosis in foetal neurons (Liu et al. 2011). CXCL10 
has also been strongly implicated in Guillain-Barré syn-
drome pathogenesis (Chiang and Ubogu 2013). Thus, we 
hypothesize that the high levels of CXCL10 in ZIKV pa-
tients may contribute to neuronal damage affecting the 
developing foetal brain and potentially targeting periph-
eral nerves in Guillain-Barré syndrome as well. Consist-
ent with this hypothesis, Kam et al. (2017) specifically 
identified higher levels of CXCL10 in ZIKV-infected 
patients with neurological complications compared to 
those without and higher levels of CXCL10 in ZIKV-in-
fected pregnant women carrying babies with foetal 
growth associated malformations.
High levels of CXCL10 have been previously described 
in acute and convalescent phases, with more prominent 
expression in the latter (Tappe et al. 2016). Unfortunate-
ly, although our data strongly suggest that CXCL10 is a 
biomarker of acute ZIKV infection, we were unable to 
perform a longitudinal analysis to verify its kinetics in or-
der to further confirm whether the concentrations of this 
chemokine would be down or up-regulated across differ-
ent stages of the disease. In addition, CXCL10 elevation is 
also observed in pre-eclampsia and hypertension in preg-
nancy, which can result in a range of foetal injuries in-
cluding intrauterine growth retardation and neurological 
damage induced by hypoxia (Gotsch et al. 2007). Thus, it 
is reasonable to suggest that ZIKV-induced inflammation 
may increase the frequency of foetal injuries.
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CXCL10 may also be an important therapeutic target 
(Liu et al. 2011). For example, CXCL10 neutralization by 
specific antibodies or genetic deletion in CXCL10-/-mice 
protected against cerebral malaria infection and inflamma-
tion (Nie et al. 2009). Passive transfer of anti-CXCL10 anti-
bodies reduced inflammatory leukocyte recruitment across 
the blood-brain barrier. Furthermore, statin medications 
commonly used for cholesterol control have been shown to 
decrease CXCL10 and to be effective in CXCL10-mediated 
Crohn’s disease (Grip and Janciauskiene 2009).
In this work, we also describe the relationship be-
tween the timing of viremia and cytokine elevations. 
We assessed the acute phase biomarkers and viral titres 
at different time points (until day 5). Augmented levels 
of CCL4, CCL2, CCL5, CXCL5, CXCL10, IL-6, IL-4, 
PDGF, and G-CSF immunomodulators were observed at 
all time points. The peaks of viremia, at Day 2 and Day 
4, were accompanied by increased TNF-a levels. IL-10 
elevation appeared to be directly related to the lowest 
virus titres (Day 3 and Day 5), while the highest levels 
of IL-12 were found at Day 5. These findings allow us 
to deduce that the acute phase of ZIKV is characterized 
mainly by an innate immune system inflammatory re-
sponse, with overlap of the inflammatory biomarkers and 
viremia peaks, while the anti-inflammatory response co-
incides with viremia decay. Altogether, this study iden-
tifies unique characteristics of the acute inflammatory 
and multifactorial immune response induced by ZIKV 
and identifies CXCL10 as a potential biomarker of acute 
infection and, perhaps, a predictor of severity. Neverthe-
less, further longitudinal studies that measure the host 
immunopathological response at several time points are 
required to better characterize the immunological factors 
involved in Zika disease. The altered concentrations of 
serum biomarkers observed in this study may bring new 
insights to the ZIKV immunopathology puzzle.
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